Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LV5FU2 With or Without Irinotecan in Elderly Patients With Advanced Colorectal Cancer
NCT00303771Phase 3Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Jun 2003
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of irinotecan in colorectal cancer (CRC) (4 arms), sponsored by Fédération Francophone de Cancérologie Digestive. Primary endpoint: Progression-Free Survival. Started Jun 2003; status: completed.
02
Drugs
irinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00303771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00303771.